Preprint
Review

Widely Available Lysosomotropic Agents Should Be Considered as a Potential Therapy for COVID-19

This version is not peer-reviewed.

Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2025 MDPI (Basel, Switzerland) unless otherwise stated